229 related articles for article (PubMed ID: 33639914)
21. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of preoperative thrombocytosis in patients who underwent radical nephrectomy for nonmetastatic renal cell carcinoma.
Choi JY; Ko YH; Song PH
Investig Clin Urol; 2016 Sep; 57(5):324-9. PubMed ID: 27617313
[TBL] [Abstract][Full Text] [Related]
23. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma.
Bertini R; Roscigno M; Freschi M; Strada E; Angiolilli D; Petralia G; Matloob R; Sozzi F; Capitanio U; Da Pozzo LF; Colombo R; Guazzoni G; Cremonini A; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):358-65. PubMed ID: 21640483
[TBL] [Abstract][Full Text] [Related]
24. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
[TBL] [Abstract][Full Text] [Related]
25. Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series.
Brookman-May S; May M; Ficarra V; Kainz MC; Kampel-Kettner K; Kohlschreiber S; Wenzl V; Schneider M; Burger M; Wieland WF; Otto W; Tilki D; Gilfrich C; Hohenfellner M; Pahernik S; Chromecki TF; Stief C; Zigeuner R;
World J Urol; 2013 Oct; 31(5):1309-16. PubMed ID: 22903790
[TBL] [Abstract][Full Text] [Related]
26. Significance of thrombocytosis for determining prognosis in patients with localized renal cell carcinoma.
Göğüş C; Baltaci S; Filiz E; Elhan A; Bedük Y
Urology; 2004 Mar; 63(3):447-50. PubMed ID: 15028435
[TBL] [Abstract][Full Text] [Related]
27. Impacts of clinicopathologic and operative factors on short-term and long-term survival in renal cell carcinoma with venous tumor thrombus extension: a multi-institutional retrospective study in Japan.
Hirono M; Kobayashi M; Tsushima T; Obara W; Shinohara N; Ito K; Eto M; Takayama T; Fujii Y; Nishikido M; Kimura G; Kishida T; Takahashi M; Miyao N; Naya Y; Abe T; Fujioka T; Ito K; Naito S;
BMC Cancer; 2013 Oct; 13():447. PubMed ID: 24083566
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of prognostic nutritional index in renal cell carcinomas.
Tang Y; Liang J; Liu Z; Zhang R; Zou Z; Wu K; Lu Y; Wei X
Medicine (Baltimore); 2021 Mar; 100(10):e25127. PubMed ID: 33725913
[TBL] [Abstract][Full Text] [Related]
29. Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus.
Haddad AQ; Leibovich BC; Abel EJ; Luo JH; Krabbe LM; Thompson RH; Heckman JE; Merrill MM; Gayed BA; Sagalowsky AI; Boorjian SA; Wood CG; Margulis V
Urol Oncol; 2015 Sep; 33(9):388.e1-9. PubMed ID: 26004163
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for recurrence after surgery in non-metastatic RCC with thrombus: a contemporary multicentre analysis.
Abel EJ; Margulis V; Bauman TM; Karam JA; Christensen WP; Krabbe LM; Haddad A; Golla V; Wood CG
BJU Int; 2016 Jun; 117(6B):E87-94. PubMed ID: 26305276
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors of renal cell carcinoma with extension into inferior vena cava.
Tanaka M; Fujimoto K; Okajima E; Tanaka N; Yoshida K; Hirao Y
Int J Urol; 2008 May; 15(5):394-8. PubMed ID: 18452454
[TBL] [Abstract][Full Text] [Related]
32. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
Tilki D; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Koppie TM; Lorentz CA; Mandel P; Martinez-Salamanca JI; Master VA; Matloob R; McKiernan JM; Mlynarczyk CM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Ramaswamy K; Rodriguez Faba O; Russo P; Shariat SF; Spahn M; Terrone C; Vergho D; Wallen EM; Xylinas E; Zigeuner R; Libertino JA; Evans CP
Eur Urol; 2014 Sep; 66(3):577-83. PubMed ID: 23871402
[TBL] [Abstract][Full Text] [Related]
33. Extent of lymph node dissection improves overall survival in pT3N0 non-metastatic renal cell carcinoma patients treated with radical nephrectomy: a propensity score-based analysis.
Wei Y; Wang M; Jin Y; Zhou C; Lyu J
World J Urol; 2020 Jun; 38(6):1579-1585. PubMed ID: 31065795
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
[TBL] [Abstract][Full Text] [Related]
35. Impact of E-Cadherin and β-Catenin as Prognostic Factor in Renal Cell Carcinoma with Tumor Thrombus of the Vena Cava.
Spachmann PJ; Breyer J; Kalogirou C; Lausenmeyer EM; Weber F; Prohaska S; Denzinger S; Burger M; Kübler H; Otto W; Vergho D
Urol Int; 2019; 102(4):413-420. PubMed ID: 30844790
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of efficacy between sorafenib and sunitinib as first-line therapy for metastatic renal cell carcinoma and analyze prognostic factors for survival].
Cai W; Yuan YC; Li MY; Kong W; Dong BJ; Chen YH; Zhang J; Xue W; Huang YR; Zhou LX; Huang JW
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):384-389. PubMed ID: 29860767
[No Abstract] [Full Text] [Related]
37. Thrombocytosis and hematocrit as prognostic factors in renal carcinoma.
Seda CJ; Salas AS; Sánchez CG; Blasco JM; García IO; Sánchez JM; Ruíz CB; Navarro SM; López RA
Arch Esp Urol; 2011 Nov; 64(9):883-90. PubMed ID: 22155876
[TBL] [Abstract][Full Text] [Related]
38. The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013.
Golijanin B; Pereira J; Mueller-Leonhard C; Golijanin D; Amin A; Mega A; Boorjian SA; Thompson RH; Leibovich BC; Gershman B
Urol Oncol; 2019 Dec; 37(12):932-940. PubMed ID: 31570248
[TBL] [Abstract][Full Text] [Related]
39. Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma.
Sun J; Ning H; Sun J; Qu X
Urol Oncol; 2016 May; 34(5):239.e9-15. PubMed ID: 26803433
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic value of venous tumor thrombus in renal cell carcinoma].
García-Fadrique G; Budía-Alba A; Ruiz-Cerdá JL; Morales-Solchaga G; Pontones JL; Jiménez-Cruz JF
Actas Urol Esp; 2012 Jan; 36(1):29-34. PubMed ID: 21802784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
